Free Trial

Lyra Therapeutics (LYRA) Earnings Date, Estimates & Call Transcripts

Lyra Therapeutics logo
$0.11 0.00 (-2.87%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.11 +0.00 (+2.49%)
As of 04:57 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lyra Therapeutics Earnings Summary

Latest Q4
Earnings Date
Mar. 13Estimated
Consensus EPS
(Mar. 13)
-$0.12
Actual EPS
(Mar. 13)
-$0.16 Missed By -$0.04
Actual Revenue
(Mar. 13)
$0.21M

Lyra Therapeutics posted Q4 2024 earnings on March 13, 2025, reporting an EPS of -$0.16, which missed the consensus estimate of -$0.12 by $0.04. Quarterly revenue was reported to be $0.21 million, above the consensus estimate of $0.21 million. With a trailing EPS of -$1.43, Lyra Therapeutics' earnings are expected to grow next year, from ($0.93) to ($0.58) per share.

Q4 2024 Earnings Resources

Get Lyra Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Lyra Therapeutics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

LYRA Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LYRA Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lyra Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20251-$0.12-$0.12-$0.12
Q2 20251-$0.12-$0.12-$0.12
Q3 20251-$0.12-$0.12-$0.12
Q4 20251-$0.16-$0.16-$0.16

Lyra Therapeutics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
3/13/2025Q4 2024-$0.12-$0.16 -$0.04-$0.16$0.21M$0.21M
8/14/2024Q2 2024-$0.34-$0.29+$0.05$0.16$0.43M$0.60M
4/30/2024Q1 2024-$0.26-$0.35 -$0.09-$0.35$0.40M$0.53M
3/21/2024Q4 2023-$0.33-$0.22+$0.11-$0.22$0.52M$0.15M
11/7/2023Q3 2023-$0.33-$0.27+$0.06-$0.27$0.48M$0.54M
8/8/2023Q2 2023-$0.44-$0.33+$0.11-$0.30$0.41M$0.46M
5/12/2023Q1 2023-$0.36-$0.44 -$0.08-$0.44$0.32M$0.41M

Lyra Therapeutics Earnings - Frequently Asked Questions

Lyra Therapeutics (NASDAQ:LYRA) last announced its quarterly earning data on Thursday, March 13, 2025. Learn more on LYRA's earnings history.

In the previous quarter, Lyra Therapeutics (NASDAQ:LYRA) missed the analysts' consensus estimate of ($0.12) by $0.04 with a reported earnings per share (EPS) of ($0.16). Learn more on analysts' earnings estimate vs. LYRA's actual earnings.

Lyra Therapeutics (NASDAQ:LYRA) has a recorded annual revenue of $1.53 million.

Lyra Therapeutics (NASDAQ:LYRA) has a recorded net income of -$62.68 million. LYRA has generated -$1.43 earnings per share over the last four quarters.

Lyra Therapeutics's earnings are expected to grow from ($0.93) per share to ($0.58) per share in the next year.

More Earnings Resources from MarketBeat



This page (NASDAQ:LYRA) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners